-Alina Kotlyar Researcher Activity Profile

Research Author Detailed Information 

Alina Kotlyar Publication Rate By Year

Alina Kotlyar has published 1 paper(s) in 2005, 1 paper(s) in 2006, 2 paper(s) in 2007, 5 paper(s) in 2008, for a total of 9 research publications in total.

Alina A Kotlyar Author Information

LAST NAME: kotlyar

FIRST NAME: alina

INITIALS: A

AFFILIATION:

Papers

Alina Kotlyar's Publication Record

1. Tumor angiogenic vasculature targeting with PAMAM dendrimer-RGD conjugates. Year Published: 2005
Michigan Nanotechnology Institute for Medicine and Biological Science, Department of Internal Medicine, Division of Allergy, University of Michigan, Ann Arbor, 48109, USA.
2. HER2 specific tumor targeting with dendrimer conjugated anti-HER2 mAb. Year Published: 2006
Michigan Nanotechnology Institute for Medicine and Biological Sciences, Department of Internal Medicine, Division of Allergy, University of Michigan, 9220 MSRB III, Box 0648, Ann Arbor, 48109, USA.
3. Synthesis, characterization, and intracellular uptake of carboxyl-terminated poly(amidoamine) dendrimer-stabilized iron oxide nanoparticles. Year Published: 2007
Michigan Nanotechnology Institute for Medicine and Biological Sciences, University of Michigan, Ann Arbor, MI 48109-0533, USA.
4. Preclinical antitumor efficacy evaluation of dendrimer-based methotrexate conjugates. Year Published: 2008
Michigan Nanotechnology Institute for Medicine and Biological Sciences, University of Michigan Medical School, BSRB, Ann Arbor, Michigan, USA.
5. Synthesis, characterization, and intracellular uptake of carboxyl-terminated poly(amidoamine) dendrimer-stabilized iron oxide nanoparticles. Year Published: 2007
Michigan Nanotechnology Institute for Medicine and Biological Sciences, University of Michigan, Ann Arbor, MI 48109-0533, USA.
6. Preclinical antitumor efficacy evaluation of dendrimer-based methotrexate conjugates. Year Published: 2008
Michigan Nanotechnology Institute for Medicine and Biological Sciences, University of Michigan Medical School, BSRB, Ann Arbor, Michigan 48109, USA. myca@umich.edu
7. Dendrimer-epidermal growth factor conjugate displays superagonist activity. Year Published: 2008
Michigan Nanotechnology Institute for Medicine and Biological Sciences, Department of Internal Medicine, Division of Allergy, University of Michigan, 9220 MSRB III, Box 0648, Ann Arbor, Michigan 48109, USA.
8. Dendrimer-epidermal growth factor conjugate displays superagonist activity. Year Published: 2008
Michigan Nanotechnology Institute for Medicine and Biological Sciences, Department of Internal Medicine, Division of Allergy, University of Michigan, 9220 MSRB III, Box 0648, Ann Arbor, Michigan 48109, USA.
9. Preclinical antitumor efficacy evaluation of dendrimer-based methotrexate conjugates. Year Published: 2008
Michigan Nanotechnology Institute for Medicine and Biological Sciences, University of Michigan Medical School, BSRB, Ann Arbor, Michigan 48109, USA. myca@umich.edu